SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India informs about company updates

22 Aug 2019 Evaluate

US FDA has completed inspection of the facility of Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary of the Company located in Chantilly, Virginia, USA on 21St August 2019 with two minor observations. This is a pre-approval inspection for seven products filed from this facility. Granules Pharmaceuticals, Inc will respond to these observations within the stipulated time period.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

674.55 20.15 (3.08%)
20-Apr-2026 11:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.60
Dr. Reddys Lab 1237.20
Cipla 1235.85
Zydus Lifesciences 941.30
Lupin 2323.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×